Filing Details

Accession Number:
0001567619-20-019312
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-11-12 17:01:20
Reporting Period:
2020-11-10
Accepted Time:
2020-11-12 17:01:20
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
874716 Idexx Laboratories Inc IDXX In Vitro & In Vivo Diagnostic Substances (2835) 010393723
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1254748 M Rebecca Henderson One Idexx Drive
Westbrook ME 04092
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2020-11-10 5,902 $85.00 20,598 No 4 M Direct
Common Stock Disposition 2020-11-10 45 $435.92 20,553 No 4 S Direct
Common Stock Disposition 2020-11-10 5,857 $435.91 14,696 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Non-Qualified Stock Option (right-to-buy) Disposition 2020-11-10 5,902 $0.00 5,902 $85.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2026-05-03 No 4 M Direct
Footnotes
  1. Grant of option to buy shares of IDEXX Laboratories, Inc. common stock that became exercisable on May 4, 2017.
  2. Not applicable.